Your browser doesn't support javascript.
loading
The thyroid receptor ß modulator GC-1 reduces atherosclerosis in ApoE deficient mice.
Kannisto, K; Rehnmark, S; Slätis, K; Webb, P; Larsson, L; Gåfvels, M; Eggertsen, G; Parini, P.
Affiliation
  • Kannisto K; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden.
  • Rehnmark S; Axcentua Pharmaceuticals AB, Huddinge, Sweden.
  • Slätis K; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden.
  • Webb P; Houston Methodist Research Institute, Houston, TX, USA.
  • Larsson L; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden.
  • Gåfvels M; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden.
  • Eggertsen G; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden.
  • Parini P; Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden. Electronic address: paolo.parini@ki.se.
Atherosclerosis ; 237(2): 544-54, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25463087
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenols / Cholesterol / Thyroid Hormone Receptors beta / Atherosclerosis / Acetates Type of study: Prognostic_studies Limits: Animals Language: En Journal: Atherosclerosis Year: 2014 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenols / Cholesterol / Thyroid Hormone Receptors beta / Atherosclerosis / Acetates Type of study: Prognostic_studies Limits: Animals Language: En Journal: Atherosclerosis Year: 2014 Type: Article Affiliation country: Sweden